HEADER CELL CYCLE 18-OCT-10 3PA6 TITLE STRUCTURE OF THE N-TERMINAL BRCT DOMAIN OF HUMAN MICROCEPHALIN (MCPH1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: MICROCEPHALIN; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: BRCT DOMAIN, UNP RESIDUES 1-105; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MCPH1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGB1 KEYWDS BRCT DOMAIN, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR N.SINGH,A.HEROUX,J.R.THOMPSON,G.MER REVDAT 2 08-NOV-17 3PA6 1 REMARK REVDAT 1 08-DEC-10 3PA6 0 JRNL AUTH N.SINGH,A.HEROUX,J.R.THOMPSON,G.MER JRNL TITL STRUCTURE OF THE N-TERMINAL BRCT DOMAIN OF HUMAN JRNL TITL 2 MICROCEPHALIN (MCPH1) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.1_357) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 3 NUMBER OF REFLECTIONS : 41554 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.146 REMARK 3 R VALUE (WORKING SET) : 0.144 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.890 REMARK 3 FREE R VALUE TEST SET COUNT : 2032 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1106.8713 - 3.2337 1.00 4555 260 0.1552 0.1742 REMARK 3 2 3.2337 - 2.5666 1.00 4530 204 0.1302 0.1962 REMARK 3 3 2.5666 - 2.2422 1.00 4436 251 0.1189 0.1920 REMARK 3 4 2.2422 - 2.0371 1.00 4403 251 0.1155 0.1733 REMARK 3 5 2.0371 - 1.8911 1.00 4421 235 0.1161 0.2068 REMARK 3 6 1.8911 - 1.7796 1.00 4403 236 0.1421 0.1927 REMARK 3 7 1.7796 - 1.6905 0.99 4383 214 0.1551 0.2054 REMARK 3 8 1.6905 - 1.6169 0.85 3797 181 0.1707 0.2202 REMARK 3 9 1.6169 - 1.5546 0.63 2794 118 0.1962 0.2143 REMARK 3 10 1.5546 - 1.5010 0.41 1800 82 0.2315 0.2762 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.50 REMARK 3 B_SOL : 78.52 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.69650 REMARK 3 B22 (A**2) : 2.00720 REMARK 3 B33 (A**2) : -11.38200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.16180 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 2386 REMARK 3 ANGLE : 1.339 3249 REMARK 3 CHIRALITY : 0.080 372 REMARK 3 PLANARITY : 0.008 403 REMARK 3 DIHEDRAL : 13.970 871 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3PA6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1000062149. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979095 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41554 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 35.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 46.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 43.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.43100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: HKL2MAP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM SUCCINATE, 15% PEG 3350, REMARK 280 PH 7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 19.63700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 HIS A 0 REMARK 465 MSE A 1 REMARK 465 SER A 101 REMARK 465 SER A 102 REMARK 465 LEU A 103 REMARK 465 ILE A 104 REMARK 465 LYS A 105 REMARK 465 GLY B -1 REMARK 465 HIS B 0 REMARK 465 MSE B 1 REMARK 465 GLU B 98 REMARK 465 HIS B 99 REMARK 465 LEU B 100 REMARK 465 SER B 101 REMARK 465 SER B 102 REMARK 465 LEU B 103 REMARK 465 ILE B 104 REMARK 465 LYS B 105 REMARK 465 GLY C -1 REMARK 465 HIS C 0 REMARK 465 MSE C 1 REMARK 465 ALA C 2 REMARK 465 ALA C 3 REMARK 465 MSE C 96 REMARK 465 ASN C 97 REMARK 465 GLU C 98 REMARK 465 HIS C 99 REMARK 465 LEU C 100 REMARK 465 SER C 101 REMARK 465 SER C 102 REMARK 465 LEU C 103 REMARK 465 ILE C 104 REMARK 465 LYS C 105 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ILE A 51 CA CB CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H LYS B 7 HD1 HIS B 85 1.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 204 O HOH B 118 1665 1.96 REMARK 500 O HOH A 215 O HOH B 166 1665 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP C 8 37.10 -93.69 REMARK 500 ALA C 82 -5.55 -57.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 106 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KTF RELATED DB: PDB REMARK 900 STRUCTURE OF THE N-TERMINAL BRCT DOMAIN OF HUMAN MICROCEPHALIN REMARK 900 (MCPH1) DBREF 3PA6 A 1 105 UNP Q8NEM0 MCPH1_HUMAN 1 105 DBREF 3PA6 B 1 105 UNP Q8NEM0 MCPH1_HUMAN 1 105 DBREF 3PA6 C 1 105 UNP Q8NEM0 MCPH1_HUMAN 1 105 SEQADV 3PA6 GLY A -1 UNP Q8NEM0 EXPRESSION TAG SEQADV 3PA6 HIS A 0 UNP Q8NEM0 EXPRESSION TAG SEQADV 3PA6 GLY B -1 UNP Q8NEM0 EXPRESSION TAG SEQADV 3PA6 HIS B 0 UNP Q8NEM0 EXPRESSION TAG SEQADV 3PA6 GLY C -1 UNP Q8NEM0 EXPRESSION TAG SEQADV 3PA6 HIS C 0 UNP Q8NEM0 EXPRESSION TAG SEQRES 1 A 107 GLY HIS MSE ALA ALA PRO ILE LEU LYS ASP VAL VAL ALA SEQRES 2 A 107 TYR VAL GLU VAL TRP SER SER ASN GLY THR GLU ASN TYR SEQRES 3 A 107 SER LYS THR PHE THR THR GLN LEU VAL ASP MSE GLY ALA SEQRES 4 A 107 LYS VAL SER LYS THR PHE ASN LYS GLN VAL THR HIS VAL SEQRES 5 A 107 ILE PHE LYS ASP GLY TYR GLN SER THR TRP ASP LYS ALA SEQRES 6 A 107 GLN LYS ARG GLY VAL LYS LEU VAL SER VAL LEU TRP VAL SEQRES 7 A 107 GLU LYS CYS ARG THR ALA GLY ALA HIS ILE ASP GLU SER SEQRES 8 A 107 LEU PHE PRO ALA ALA ASN MSE ASN GLU HIS LEU SER SER SEQRES 9 A 107 LEU ILE LYS SEQRES 1 B 107 GLY HIS MSE ALA ALA PRO ILE LEU LYS ASP VAL VAL ALA SEQRES 2 B 107 TYR VAL GLU VAL TRP SER SER ASN GLY THR GLU ASN TYR SEQRES 3 B 107 SER LYS THR PHE THR THR GLN LEU VAL ASP MSE GLY ALA SEQRES 4 B 107 LYS VAL SER LYS THR PHE ASN LYS GLN VAL THR HIS VAL SEQRES 5 B 107 ILE PHE LYS ASP GLY TYR GLN SER THR TRP ASP LYS ALA SEQRES 6 B 107 GLN LYS ARG GLY VAL LYS LEU VAL SER VAL LEU TRP VAL SEQRES 7 B 107 GLU LYS CYS ARG THR ALA GLY ALA HIS ILE ASP GLU SER SEQRES 8 B 107 LEU PHE PRO ALA ALA ASN MSE ASN GLU HIS LEU SER SER SEQRES 9 B 107 LEU ILE LYS SEQRES 1 C 107 GLY HIS MSE ALA ALA PRO ILE LEU LYS ASP VAL VAL ALA SEQRES 2 C 107 TYR VAL GLU VAL TRP SER SER ASN GLY THR GLU ASN TYR SEQRES 3 C 107 SER LYS THR PHE THR THR GLN LEU VAL ASP MSE GLY ALA SEQRES 4 C 107 LYS VAL SER LYS THR PHE ASN LYS GLN VAL THR HIS VAL SEQRES 5 C 107 ILE PHE LYS ASP GLY TYR GLN SER THR TRP ASP LYS ALA SEQRES 6 C 107 GLN LYS ARG GLY VAL LYS LEU VAL SER VAL LEU TRP VAL SEQRES 7 C 107 GLU LYS CYS ARG THR ALA GLY ALA HIS ILE ASP GLU SER SEQRES 8 C 107 LEU PHE PRO ALA ALA ASN MSE ASN GLU HIS LEU SER SER SEQRES 9 C 107 LEU ILE LYS MODRES 3PA6 MSE A 35 MET SELENOMETHIONINE MODRES 3PA6 MSE A 96 MET SELENOMETHIONINE MODRES 3PA6 MSE B 35 MET SELENOMETHIONINE MODRES 3PA6 MSE B 96 MET SELENOMETHIONINE MODRES 3PA6 MSE C 35 MET SELENOMETHIONINE HET MSE A 35 17 HET MSE A 96 17 HET MSE B 35 31 HET MSE B 96 17 HET MSE C 35 17 HET CL A 106 1 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION FORMUL 1 MSE 5(C5 H11 N O2 SE) FORMUL 4 CL CL 1- FORMUL 5 HOH *313(H2 O) HELIX 1 1 TYR A 24 MSE A 35 1 12 HELIX 2 2 TYR A 56 GLY A 67 1 12 HELIX 3 3 SER A 72 GLY A 83 1 12 HELIX 4 4 ASP A 87 PHE A 91 5 5 HELIX 5 5 TYR B 24 MSE B 35 1 12 HELIX 6 6 TYR B 56 GLY B 67 1 12 HELIX 7 7 SER B 72 GLY B 83 1 12 HELIX 8 8 ASP B 87 PHE B 91 5 5 HELIX 9 9 TYR C 24 MSE C 35 1 12 HELIX 10 10 TYR C 56 GLY C 67 1 12 HELIX 11 11 SER C 72 GLY C 83 1 12 HELIX 12 12 ASP C 87 PHE C 91 5 5 SHEET 1 A 4 LYS A 38 VAL A 39 0 SHEET 2 A 4 VAL A 10 VAL A 15 1 N ALA A 11 O LYS A 38 SHEET 3 A 4 HIS A 49 LYS A 53 1 O ILE A 51 N GLU A 14 SHEET 4 A 4 LYS A 69 VAL A 71 1 O LYS A 69 N VAL A 50 SHEET 1 B 4 LYS B 38 VAL B 39 0 SHEET 2 B 4 VAL B 10 VAL B 15 1 N ALA B 11 O LYS B 38 SHEET 3 B 4 HIS B 49 LYS B 53 1 O ILE B 51 N GLU B 14 SHEET 4 B 4 LYS B 69 VAL B 71 1 O LYS B 69 N VAL B 50 SHEET 1 C 4 LYS C 38 VAL C 39 0 SHEET 2 C 4 VAL C 10 VAL C 15 1 N ALA C 11 O LYS C 38 SHEET 3 C 4 HIS C 49 LYS C 53 1 O ILE C 51 N GLU C 14 SHEET 4 C 4 LYS C 69 VAL C 71 1 O LYS C 69 N VAL C 50 LINK C ASP A 34 N MSE A 35 1555 1555 1.33 LINK C MSE A 35 N GLY A 36 1555 1555 1.34 LINK C ASN A 95 N MSE A 96 1555 1555 1.33 LINK C MSE A 96 N ASN A 97 1555 1555 1.33 LINK C ASP B 34 N MSE B 35 1555 1555 1.34 LINK C MSE B 35 N GLY B 36 1555 1555 1.34 LINK C ASN B 95 N MSE B 96 1555 1555 1.33 LINK C MSE B 96 N ASN B 97 1555 1555 1.33 LINK C ASP C 34 N MSE C 35 1555 1555 1.34 LINK C MSE C 35 N GLY C 36 1555 1555 1.33 SITE 1 AC1 4 SER A 17 SER A 18 LYS A 53 ASP B 87 CRYST1 35.069 39.274 106.639 90.00 91.52 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028515 0.000000 0.000757 0.00000 SCALE2 0.000000 0.025462 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009381 0.00000